Search Within

Martin Fleisher

Formats
  1. Journal Article (161)
  2. Meeting Abstract (140)
  3. Book Section (6)
  4. Conference Paper (4)
  5. Book Whole (1)
Groups
  1. Department of Medicine (180)
  2. Solid Tumor Oncology Division (113)
  3. Genitourinary Oncology Service (81)
  4. Epidemiology and Biostatistics (77)
  5. Hematologic Malignancies, Division of (67)
  6. Biostatistics Service (64)

More Groups

People
  1. Howard Scher (78)
  2. Daniel Danila (48)
  3. Raymond Comenzo (36)
  4. Aseem Anand (34)
  5. Glenn Heller (32)
  6. Ping Zhou (30)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (59)
  2. Clinical Chemistry (32)
  3. Blood (26)
  4. Clinical Cancer Research (10)
  5. Cancer Research (9)
  6. Neuro-Oncology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (60)
  2. American Association for Clinical Chemistry (32)
  3. American Association for Cancer Research (26)
  4. American Society of Hematology (26)
  5. Oxford University Press (19)
  6. Elsevier Inc. (16)

More Publishers

Results (312)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgery
    Journal Article

    Sprenkle, P. C.; Wren, J.; Maschino, A. C.; Feifer, A.; Power, N.; Ghoneim, T.; Sternberg, I.; Fleisher, M.; Russo, P.
    Journal of Urology (2013)

    Fulltext@MSK | Save
  • Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors
    Journal Article

    Nayak, L.; Fleisher, M.; Gonzalez-Espinoza, R.; Lin, O.; Panageas, K.; Reiner, A.; Liu, C. M.; De Angelis, L. M.; Omuro, A.
    Neurology (2013)

    Fulltext@MSK | Save
  • Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors
    Journal Article

    Berman, E.; Girotra, M.; Cheng, C.; Chanel, S.; Maki, R.; Shelat, M.; Strauss, H. W.; Fleisher, M.; Heller, G.; Farooki, A.
    Leukemia Research (2013)

    Fulltext@MSK | Save
  • The analytic validation of prostate-specific mRNA detection in whole blood by RT-PCR as a prognostic biomarker for patients with castration- resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase I study of the androgen signaling inhibitor ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Curley, T.; Rix, P. J.; Maneval, E. C.; Chen, I.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A validated whole-blood RNA transcript-based prognostic model that predicts survival in men with castration-resistant prostate cancer
    Meeting Abstract

    Oh, W. K.; Kantoff, P.; Scher, H. I.; Magidson, J.; Wassmann, K.; Lee, G. S. M.; Katz, L. M.; Subudhi, S. K.; Anand, A.; Fleisher, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Predictive biomarkers in circulating tumor cells (CTC) from patients with castration-resistant prostate cancer (CRPC) through genomic analysis
    Meeting Abstract

    Danila, D. C.; Anand, A.; Yao, J.; Gierszewska, M.; Kramer, M.; Muller, S.; Fleisher, M.; McCombie, W. R.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Predictive biomarkers in circulating tumor cells (CTC) from patients with castration-resistant prostate cancer (CRPC) through genomic analysis
    Meeting Abstract

    Danila, D. C.; Anand, A.; Yao, J.; Gierszewska, M.; Kramer, M.; Muller, S.; Fleisher, M.; McCombie, W. R.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I/II safety and pharmacokinetic (PK) study of ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase I results of a Prostate Cancer Clinical Trials Consortium study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Rix, P. J.; Maneval, E. C.; Chen, I.; Fox, J. J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Generation of a novel, multi-stage, progressive, and transplantable model of multiple myeloma
    Meeting Abstract

    Asai, T.; Menendez, S.; Ndiaye-Lobry, D.; Deblasio, A. R.; Murata, K.; Fleisher, M.; Petrini, J.; Nimer, S. D.
    Blood (2012)

    Fulltext@MSK | Save